Arkolith/Insider Trading/IGC/Form 4

Mukunda Ram

CEO, DirectorIGC Pharma, Inc. (IGC) · full profile →Form 4 · filed Jun 27, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
14
5 non-derivative · 9 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 23, 2023Gift(G)400K—$03.2M
Mar 31, 2023Option exercise(M)17K—$0761K
Mar 31, 2023Option exercise(M)333K—$03.3M
Mar 31, 2023Option exercise(M)17K—$0777K
Mar 31, 2023Option exercise(M)233K—$03.6M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 20, 2023Grant(A)50K—$050K
Jun 20, 2023Grant(A)1.0M—$01.0M
Jun 20, 2023Grant(A)1.0M—$01.0M
Mar 31, 2023Option exercise(M)233K—$0467K
Mar 31, 2023Option exercise(M)333K—$0333K
Mar 31, 2023Option exercise(M)17K—$017K
Mar 31, 2023Option exercise(M)13K—$013K
May 25, 2022Grant(A)700K—$0700K
May 25, 2022Grant(A)50K—$050K

Transaction Codes

G
Gift
M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001185185-23-000662) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML